[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/main/docs/Technology/index.md) >> Individual ID:PBN__Technology_838 

# __antiviral drug research__

## Closest similar item

* [antiviral drugs](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_236.md)
* [antiviral](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3919.md)
* [antivirals](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_829.md)
* [advanced antiviral technologies](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_792.md)
* [antiretroviral therapy](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_2809.md)
* [viral testing kits](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3878.md)
* [viral enrichment](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_4481.md)
* [antivirus software](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1920.md)
* [improved virus concentration methods](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_59.md)
* [Improved virus concentration methods](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_2788.md)

## Risks linked to this technology

* [Lack of vaccines and agent-specific drugs](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1540.md)

## This Technology belongs to this TechSubgroup

* [Preventive Measures and Public Health Initiatives](https://github.com/mm80843/T3.5/blob/main/docs/TechSubgroup/PBN__TechSubgroup_24.md)

## This Technology is identified by the following QID

* [Q40207875](https://github.com/mm80843/T3.5/blob/main/docs//Qid/Q40207875.md)

## This Technology belongs to this TechGroup

* [Telehealth](https://github.com/mm80843/T3.5/blob/main/docs/TechGroup/PBN__TechGroup_3.md)

